AlphAIalphai — Financial news for AI agents
investing.comAUG 242 min read$OSCR

Oscar Health stock hits 52-week high at 33.54 USD

Oscar Health (OSCR) hit a 52-week high of $33.54, with a 90.7% total return over the past year. The company reported Q2 2026 adjusted earnings of $1.10 per share, beating estimates of $0.37, and revenue of $4.88 billion, exceeding expectations. InvestingPro suggests the stock may be overvalued, with a high beta of 2.39.

Original reporting
investing.com
Published Aug 24, 2026, 2:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 24, 2026, 4:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$OSCR
Bullish
high confidence
Mentioned
$OSCR
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$OSCRBullishHigh
01

Why it matters

Oscar Health's earnings beat stands out as a positive outlier.

02

Market read

Earnings surprise may attract short‑term buying interest despite broader market weakness.

03

What to watch

Sustaining profitability depends on cost controls and enrollment growth.

Relevance 8/10Novelty 8/10Timing: premarket

Background

Wall Street mixed with falling tech stocks and rising US‑Canada trade tensions.

Company-level read

Ticker impact

$OSCRBullishHigh confidence
Context

Q2 2026 earnings beat with adjusted EPS $1.10 vs $0.37 estimate and revenue $4.88B vs $4.73B.

Expected impact

Potential intraday rally, especially in pre‑market.

Evidence & confidence

Beat magnitude is large and market cap $10B gives material impact.

Market effects

Sector

Highlights strength in health‑tech insurers amid broader tech weakness.

Regional

May boost US health‑tech stocks, limited effect on Canada‑US trade tension narrative.

Global

Limited to US equity markets.

Counterpoint

What could challenge this read

High beta could amplify downside if broader tech sell‑off continues.

Key entities

  • Company
    Oscar Health Inc.

    US‑listed health‑tech insurer.

Read at source← All news

Related articles

AUG 24
$UNHHighAI 8/10

Health Insurer Stocks Are Soaring As Companies Get A Handle On Costs

UnitedHealth Group reported $5B in Q2 net income, with a declining medical care ratio. Shares of UnitedHealth, CVS Health, Centene, and Humana have risen significantly. Centene and Humana reported strong earnings, while Humana plans to exit some markets in 2027. Oscar Health entered new markets and saw its stock triple in six months.

forbes.com3 min
AUG 20
$OSCRHigh

OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance

Oscar Health (OSCR) shares rose 12% to a 5-year high after the company reported strong Q1 earnings and optimistic guidance for 2026. CFO Scott Blackley cited favorable industry trends and potential upside to guidance, with membership growing 56% year-over-year to 3.17 million. The company's medical loss ratio improved to 70.5% from 75.4%. OSCR stock has gained 78% over the past year.

stocktwits.com2 min
AUG 16
$AAPLMed

Why Did AAPL, OSCR, LLY Stocks Hit 52-Week Highs Today?

Apple shares (AAPL) hit a 52-week high after the company unveiled “Siri AI” at its WWDC, with the assistant using Google Gemini tech. Oscar Health (OSCR) rose to a 52-week high after reaffirming 2026 revenue guidance of $18.7B to $19B. Eli Lilly (LLY) reached a record high on positive late-stage results for oral obesity drug Foundayo and plans to seek U.S. approval for Type 2 diabetes.

stocktwits.com4 min